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Tris-treated PSII membraneThis study provides evidence for the superoxide oxidase and the superoxide reductase activity of
cytochrome b559 (cyt b559) in PSII. It is reported that in Tris-treated PSII membranes upon illumination,
both the intermediate potential (IP) and the reduced high potential (HPred) forms of cyt b559 exhibit
superoxide scavenging activity and interconversion between IP and HPred form. When Tris-treated PSII
membranes were illuminated in the presence of spin trap EMPO, the formation of superoxide anion
radical (O2
U−) was observed, as conﬁrmed by EPR spin-trapping spectroscopy. The observations that the
addition of enzymatic (superoxide dismutase) and non-enzymatic (cytochrome c, α-tocopherol and
Trolox) O2
U− scavengers prevented the light-induced conversion of IP↔HPred cyt b559 conﬁrmed that IP
and HPred cyt b559 are reduced and oxidized by O2
U−, respectively. Redox changes in cyt b559 by an
exogenous source of O2
U− reconﬁrmed the superoxide oxidase and reductase activity of cyt b559.
Furthermore, the light-induced conversion of IP to HPred form of cyt b559 was completely inhibited at
pHN8 and by chemical modiﬁcation of the imidazole ring of histidine residues using diethyl
pyrocarbonate. We proposed that a change in the environment around the heme iron, induced by the
protonation and deprotonation of His22 residue generates a favorable condition for the oxidation and
reduction of O2
U−, respectively.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionCytochrome b559 (cyt b559) is an intrinsic and essential
component of PSII in all oxygenic photosynthetic organisms [1,2].
It has been shown that cyt b559 is a heme-bridged protein
heterodimer that consists of α and β subunits encoded by psbE
and psbF genes, respectively [3,4]. The three dimensional structure
of PSII from thermophilic cyanobacteria Thermosynechococcus
elongatus and Theromosynechococcus vulcanus showed that α and
β subunits are located near to the D2 protein with the heme posed
near to the stromal edge of the membrane and perpendicular to the
membrane plane [5–8]. As the ﬁfth and sixth axial ligands of the
heme iron have been coordinated two histidine residues, His22 of
the α and His17 of the β subunits of the heterodimer [3,9].
The characteristic properties of cyt b559 is an appearance of cyt
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ll rights reserved.potential range from 400 mV to 0 mV [2]. These are high potential
(HP) (the midpoint redox potential Em∼+400 mV), the intermedi-
ate potential (IP) (Em∼+170 mV), the low potential (LP)
(Em∼+60 mV) and the very low potential (VLP) (Em∼0 mV)
forms of cyt b559 [10–15]. The conversion of HP to LP form of cyt b559
was demonstrated by treatments such as low and high pH treatment
[11,16], high concentration of detergent [11,17], uncouplers [16,18],
herbicides [18,19], mild heating [20] or ageing [16]. Whereas the
conversion of HP to LP form of cyt b559 has been widely studied in the
past, the reverse conversion of LP to HP forms of cyt b559 is poorly
understood. It has been presented that LP to HP forms of cyt b559 is
achieved by the incorporation of puriﬁed LP forms of cyt b559 into the
liposomes [21]. Mizusawa et al. have demonstrated that in the
presence of artiﬁcial electron donor, the illumination of Tris-treated
PSIImembranes resulted in the restoration of HP cyt b559 [12]. Gadjieva
et al. [22] demonstrated that the removal of molecular oxygen from
Tris-treated PSII membranes caused the reversible transition between
LP and HP form of cyt b559. The authors proposed that molecular
oxygen attacks the hydrogen bond between the imidazole ring of
histidine and carbonyl group of the polypeptide backbone. More detail
explanation of this phenomenon based on potentiometric redox
titration has established that it is not LP form rather IP form that is
converted to HP form by illumination [12] and anaerobiosis [23].
Although the functional aspect of cyt b559 has been extensively
worked out during the last three decade, the exact function of this
heme protein is still unknown. The largest focus has been given on the
involvement of cyt b559 in the cyclic electron transport around PSII as a
986 A. Tiwari, P. Pospíšil / Biochimica et Biophysica Acta 1787 (2009) 985–994protective mechanism during the process of photoinhibition [1,24]. It
has been proposed that LPox cyt b559 can accept electron from the
reduced pheophytin or plastoquinol and thus prevent the over
reduction of PSII electron acceptor side, while, HPred form protects
against donor side photoinhibition [25–27]. Barber and De Las Rivas
[26] have proposed a dual model, which describes the mechanism of
interconversion between LPox and HPred forms during the acceptor
and the donor side photoinhibition. Plastoquinone molecule bound at
Qc binding site [18,28] was proposed to maintain the electron
transport between pheophytin and heme iron [28,29]. On the opposite
site, it has been proposed that HPred cyt b559 is oxidized by P680+with
carotenoids and chlorophyll z via a sequential or branched pathway
[30–32]. Evidence has been given that cyt b559 can provide a plasto-
quinol oxidase [33,34] and also intrinsic superoxide dismutase activity
(SOD) [33,35]. An intrinsic SOD of cyt b559 has been previously
assigned to either HP or LP form of cyt b559 [33,35]. Ananyev et al. [35]
demonstrated that the dark reduction of HP cyt b559 observed after
photoreduction of HP cyt b559 is likely caused by O2
U− generated on
PSII electron acceptor side. It has been shown that the dark reduction
of HP cyt b559 was prevented under anaerobic conditions and by
heme-active ligand TCNE. Based on the observation that LP cyt b559 is
reduced by O2
U− generated by xanthine/xanthine oxidase system,
Kruk and Strzalka [33] proposed that LP cyt b559 exhibits intrinsic SOD
activity. The authors demonstrated that the reduction of LP cyt b559 is
prevented by removal of molecular oxygen or exogenous SOD.
In biological systems, O2
U− is scavenged by SOD which catalyzes
dismutation of O2
U− into molecular oxygen and hydrogen peroxide.
Reactionmechanism of SOD is based on the reduction and oxidation of
the metal center acting as a superoxide oxidase (SOO) and superoxide
reductase (SOR), respectively. The discovery of a non-heme iron SOR
provided a new insight about how O2
U− is eliminated in anaerobic
organisms without the formation of toxic molecular oxygen for them
[36–38]. After this, spectroscopic and crystallographic details were
reported by several workers for various 1Fe-SOR [39,40] and 2Fe-SOR
[37,41]. However, the few reports are available about the interaction of
heme iron with O2
U−. The most studies were focused on oxidation of
O2
U− by ferric heme iron [33,35]. We could not ﬁnd any literature,
which studied the interaction of ferrous heme iron with O2
U−.
The current study provides a new insight into O2
U− scavenging
activity of ferric and ferrous heme iron of cyt b559 in Tris-treated PSII
membranes. We present here compelling evidence that O2
U− is
involved both in the photoconversion of IP to HPred cyt b559 and the
reverse photoconversion of HPred to IP cyt b559. Thus, due to these
changes during the SOD reaction it is proposed that cyt b559 mimics
SOO and SOR functions. The either of the two contrasting phenom-
enons are selected by the redox state of the heme iron and the
environment around the imidazole ring i.e. reduced/oxidized and
protonated/deprotonated state, respectively. Our model provides the
mechanistic aspects of both the reactions based on the analogy with
the outer-sphere oxidation of O2
U− (SOO activity) and the inner-sphere
reduction of HO2
U (SOR activity).
2. Materials and methods
2.1. PSII membranes preparation
PSII membranes from spinach were prepared using the method of
Berthold et al. [42] with themodiﬁcations described in Ford and Evans
[43]. PSII membranes were resuspended in a medium containing
400mM sucrose,10mMNaCl, 5 mMCaCl2 and 40mMMes–NaOH (pH
6.5) and stored at−80 °C. Tris-treated PSII membranes were prepared
by incubation of PSII membranes (1 mg Chl ml−1) in a buffer
containing 0.8 M Tris–HCl (pH 8) for 30 min at 4 °C, in the darkness
with continuous gentle stirring. After treatment, PSII membranes
were washed twice in 400 mM sucrose, 10 mM NaCl, and 5 mM CaCl2
and 40mMMes–NaOH (pH 6.5). The oxygen evolution activity in Tris-treated membranes measured with Clark-type oxygen electrode
(HANSATECH, UK) was completely suppressed compared to control
PSII membranes. PSII activity as the electron transfer rate from DPC to
DCPIC was 300 μM of DCPIPH2 mg−1 Chl h−1. In somemeasurements,
500 U ml−1 superoxide dismutase (EC 1.15.1.1, from Bovine liver)
(Sigma), 400 μM cytochrome c (from Bovine heart) (Sigma), 250 μM
α-tocopherol (Aldrich) and 250 μM Trolox (a water-soluble analogue
of α-tocopherol) (Fluka) were added to the sample before or after
illumination, as indicated in the text.
2.2. Modiﬁcation treatment
Chemical modiﬁcation of carboxyl groups was performed using 1-
ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC) (Aldrich) as
described in [44]. PSII membranes (250 μg Chl ml−1) were treated
with 5 mM EDC (Chl:EDC ratio was 1:4 (w/w)) in 50 mMMes– NaOH
(pH 6.5),15mMNaCl, 5 mMMgCl2 and 400mM sucrose for 30min on
ice under continuous stirring in the dark. The reactionwas terminated
by the addition of a large volume of buffer solution after the
incubation period and was centrifuged immediately, followed by
two washing steps in the same solution.
Imidazole rings of the histidine residues were modiﬁed using
diethyl pyrocarbonate (DEPC) (Aldrich) according to the method of
Hegde et al. [45] with modiﬁcation described in Roncel et al. [15]. PSII
membranes (50 μg Chl ml−1) were treated with 5 mM DEPC for
15min at 25 °C under stirring. After incubation, concentrated histidine
solution was added to PSII membranes to the ﬁnal concentration of
20 mM and incubated for 1 min in the dark. PSII membranes were
twice washed and suspended in 50 mM Mes– NaOH (pH 5.5).
2.3. Optical measurements
Redox properties of cyt b559 were monitored by following the
absorbance changes using Olis RSM 1000 spectrometer (Olis Inc.,
Bogart, Georgia, USA). Tris-treated PSII membranes (100 μg Chl ml−1)
were treated in a 3 ml quartz cuvette at 20 °C using 50 μM potassium
ferricyanide (reference cuvette), 8 mM hydroquinone (test cuvette)
and 5 mM sodium ascorbate (test cuvette). Each step was followed by
dark adaptation for 5 min with a continuous slow stirring inside the
spectrophotometer using a tiny bar magnet unless stated otherwise.
After switching off the stirring, absorption spectrawere recorded from
530 nm to 580 nm. The spectrum slit width was 0.12 μm, the total
band pass 0.5 nm and the scan speed 50 nm per min. The amount of
different states of cyt b559 was calculated from the average spectra of
ﬁve measurements. Different forms of cyt b559 were determined by
treatment minus control spectrum. Total HP form was determined
by difference spectra of hydroquinone-reduced minus ferricyanide-
oxidized cyt b559. The IP formwas determined by difference spectra of
ascorbate-reduced minus hydroquinone-reduced cyt b559. The photo-
induced HPred form was determined by difference spectra of
illuminated (100 and 300 s) minus ferricyanide-oxidized dark-
adapted cyt b559. It was observed that addition of hydroquinone in
illuminated samples did not bring about further changes in peak
intensities of HP and IP forms. Therefore, it is concluded that light-
induced peak was of HPred form. Thus, it could be replaced for
calculations with hydroquinone-reduced spectra for the measure-
ments of HP form as “light minus ferricyanide spectra” and for the
measurements of IP form as “ascorbate minus light spectra” in illumi-
nated samples. We carried out several measurements in illuminated
samples by putting hydroquinone as an additional step and HP/IP
forms were calculated by using hydroquinone-reduced spectra but it
was just an additional step and did not make any difference in the
results and main ﬁnding of this work. Thus, the additional step of
using hydroquinone in illuminated samples was excluded from the
further experiments. Illumination was performed at 1000 μmol
photons m−2 s−1 intensity by 90° rotating the cuvette at each 15 s
Fig. 1. Light-induced redox changes of cyt b559. (A) Redox difference spectra of cyt b559
measured in dark and after illumination in Tris-treated PSII membranes. The samples
(100 μg Chlml−1) were illuminated using white light (1000 μmol photonsm−2 s−1) for
the period indicated in the Fig. In the left column, HP and IP spectra represent the
hydroquinone minus ferricyanide and ascorbate minus hydroquinone absorbance
spectra, respectively. In the middle and right column, HP spectra show the light minus
ferricyanide-oxidized spectra, whereas spectra of IP form represent ascorbate minus
light spectra. The spectrawere smoothed by using ﬁve points averaging of spectra using
the Origin v4.1 software. (B) Time proﬁle of formation of HP cyt b559 by illumination in
Tris-treated PSII membranes. The intensity of the absorption signal was calculated as
the height of peak at 559 nm from a reference line connecting the lowest points near
545 and 575 nm. Each data point represents the mean value of at least three
measurements ±SD.
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(Schott KL 1500, Schott AG, Mainz, Germany).
2.4. Potentiometric measurements
Potentiometric redox titrations were performed according to the
methods of Dutton [46] with some modiﬁcations described in Roncel
et al. [15]. Redox potentials were measured using potentiometer Oxi
340i (WTW GmbH, Weilheim, Germany) provided with Pt–Ag/AgCl
redox microelectrode (Pt 5900 A, Schott Instruments GmbH, Mainz,
Germany) simultaneously with absorbance changes at 559 nm. Redox
microelectrode (diameter of 5 mm) was immersed in the test cuvette
inside of the spectrophotometer in such away so that it does not affect
the light path. Prior to the measurements, samples were bubbled with
argon and measurements were performed under argon environment
at room temperature. Reductive potentiometric titrations were
performed under aerobic conditions in Tris-treated PSII membranes
(100 μg Chl ml−1) previously oxidized with 2 mM potassium
ferricyanide (Em=430 mV, pH 7). In addition to potassium
ferricyanide, the following mediators were used: 20 μM p-benzoqui-
none (Em=+280 mV, pH 7), 20 μM 2,5-dimethyl-p-benzoquinone
(Em=+180 mV, pH 7), 20 μM N-methylphenazonium methosulfate
(Em=+80 mV, pH 7), 20 μM sodium ascorbate (Em=+60 mV, pH
7), 20 μM sodium dithionite (Em=−660 mV, pH 7). The stirring was
switched on before the addition of mediators and switched off before
measurements as described above. The dilution resulting from the
titration was compensated by the addition of buffer solution in the
reference cuvette. Midpoint redox potential and fraction of reduced
cyt b559 were determined by the ﬁtting of the redox titration curve to
Nernst equation in accordance with one-electron process (n=1) for
one or two components.
2.5. EPR spin-trapping spectroscopy
The spin-trapping was accomplished by EMPO, 5-(ethoxycarbonyl)-
5-methyl-1-pyrroline N-oxide (Alexis Biochemicals, Lausen, Switzer-
land). Tris-treated PSII membranes (150 μg Chl ml−1) were
illuminated in a glass capillary tube (Blaubrand® intraMARK, Brand,
Germany) in the presence of 25 mM EMPO, 100 μM desferal, 40 mM
Mes– NaOH (pH 6.5). Illumination was performed with continuous
white light (1000 μmol photons m−2 s−1) using a halogen lamp with
a light guide (KL 1500 electronic, Schott, Germany) and spectra were
recorded using EPR spectrometer MiniScope MS200 (Magnettech
GmbH, Germany). Signal intensity was evaluated as a relative height
of the central doublet of the ﬁrst derivate of the absorption spectrum.
EPR conditions were as follows: microwave power, 10 mW; modula-
tion amplitude, 1 G; modulation frequency, 100 kHz; sweep width,
100 G; scan rate, 1.62 G s−1. Superoxide was generated from 1 mM
potassium superoxide (KO2) (Fluka) in dry dimethyl sulfoxide
(DMSO). KO2 powder was dissolved into dry DMSO previously
bubbled with argon gas. To promote dissolution of KO2 1 mM crown
ether 18-C-6 (Aldrich) was used in DMSO.
3. Results
3.1. Reversible photoconversion of IP↔HPred cyt b559 in Tris-treated
PSII membranes
Light-induced redox state and redox potential changes of cyt b559
were investigated in Tris-treated PSII membranes by measuring the
absorption changes at 559 nm. In Tris-treated PSII membranes, cyt
b559 was found in ascorbate-reducible IP form, whereas hydroqui-
none-reducible HP form was rather absent (Fig. 1A, left column).
Reductive potentiometric titrations performed under complete anae-
robic condition in Tris-treated PSII membranes which were previously
oxidized with ferricyanide showed the existence of two componentswith the midpoint redox potential Em∼+300mV and+125 mV (Fig.
2A). It was demonstrated previously that removal of molecular oxygen
converts ascorbate-reducible forms (LP/IP) into hydroquinone-redu-
cible form (HP) [22,23]. Thus, measurement of the redox potential
shift due to illumination in PSII membranes was only possible in the
presence of molecular oxygen. Although it may cause a downshift of
redox potential in the region of IP and LP form yet any interference of
molecular oxygen in the range of HP form is not reported. Therefore,
further titrations have been carried out in treated samples in aerobic
condition so as to any shift in redox potential from IP to HP form due to
illumination could be identiﬁed. Due to the interference of molecular
oxygen, reoxidation of LP form occurs below 100 mV ambient redox
potential thus complete oxidation could not be achieved. Therefore, in
aerobic titrations data points of the titration have been considered
only above 100 mV. When Tris-treated PSII membranes were
illuminated for 100 s, HPred form was observed, whereas the content
of IP cyt b559 signiﬁcantly decreased (Fig. 1A, middle column).
Potentiometric titrations performed in Tris-treated PSII membranes
illuminated for 100 s showed the existence of a component with
Fig. 3. Detection of superoxide using EPR spin-trapping spectroscopy. (A) Light-induced
EPR spin-trapping spectra of the EMPO–OOH adduct measured in Tris-treated PSII
membranes after illumination for the time period indicated in the ﬁgure. Spectra were
obtained after the illumination of the sample (150 μg Chl ml−1) with white light
(1000 μmol photons m−2 s−1) in the presence of 25 mM EMPO, 100 μM desferal and
40 mMMES– NaOH (pH 6.5). The upmost trace labeled KO2 shows the EPR signal of the
EMPO–OOH adduct generated by 1mMpotassium superoxide in dry DMSO. EPR spectra
were plotted as the ﬁrst derivative of the EPR absorption. (B) Time proﬁle of the
formation of the EMPO–OOH adduct EPR signal in Tris-treated PSII membranes. The
intensity of EPR signal was evaluated as the relative height of the central doublet of the
ﬁrst derivative of the EPR absorption spectrum.
Fig. 2. Reductive potentiometric titrations of cyt b559. (A) Tris-treated PSII membranes
(100 μg Chl ml−1) in complete anaerobic environment, (B) Tris-treated PSII membranes
(100 μg Chl ml−1) titrated in air after short bubbling of argon after illumination with
white light (1000 μmol photons m−2 s−1) for (▴), 100 s and (▵), 300 s. The symbols
show data points of the titration curve, whereas solid lines represent the best ﬁts of the
experimental data to Nernst equation in accordance with the one-electron process
(n=1) for one (A) or two (B) components. Dotted line represents the cross-over
between two redox components obtained by the ﬁtting procedure.
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treated PSII membranes caused conversion of IP cyt b559
(Em∼+125 mV) to HPred cyt b559 (Em∼+310 mV). When Tris-treated
PSIImembraneswere exposed tomore prolonged illumination for 300 s,
HPred form was completely suppressed, whereas the content of IP cyt
b559was re-established (Fig.1A, right column). Potentiometric titrations
performed in Tris-treated PSII membranes, which were illuminated for
300 s, did not show any component with Em value in the range of HP
form (Fig. 2B). Relative content of HPred cyt b559 as a function of
illumination time is shown in Fig.1B. It is clearly seen that 1) IP formwas
converted into HPred form within 40 s of continuous illumination, 2)
reoxidation of cyt b559 occurred for more than 100 s of continuous
illumination and 3) cyt b559 was completely oxidized within 180 s and
remained oxidized even after further illumination. These observations
showed that illumination of Tris-treated PSII membranes results in the
reversible photoconversion of IP↔HPred cyt b559.
3.2. Photogeneration of ROS in Tris-treated PSII membranes
To study the production of reactive oxygen species (ROS) in Tris-
treated PSII membranes, EPR spin-trapping technique was used. The
spin-trapping was accomplished in the presence of the spin trap
compound EMPO which is known to react either with superoxideanion (O2
U−) or hydroxyl (UOH) radical forming the spin trap-superoxide
(EMPO–OOH) or the spin trap-hydroxyl (EMPO–OH) adduct, respec-
tively [47,48]. Addition of EMPO to Tris-treated PSII membranes in the
dark resulted in the formation of neither EMPO–OOH nor EMPO–OH
adduct EPR signals (Fig. 3A). When Tris-treated PSII membranes were
illuminated in the presence of EMPO, EPR spectra were detected that
exhibit the peaks and hyperﬁne splitting characteristics of EMPO–OOH
adduct (Fig. 3A). Fig. 3B shows the time proﬁle of EMPO–OOH adduct
generation measured up to 300 s illumination. No EMPO–OOH adduct
EPR signal was observed when the buffered solution of pure EMPO spin
trap was illuminated. This indicates that PSII membranes are required
for the appearance of EMPO–OOH adduct (data not shown). The obser-
vation that EMPO–OOH adduct EPR signal is formed upon illumination
reveals that O2
U− is produced in Tris-treated PSII membranes.
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IP↔HPred cyt b559
To test an involvement of ROS in the reversible photoconversion
of IP↔HPred cyt b559, the effect of O2
U− and H2O2 scavengers on the
redox properties of cyt b559 was tested. When enzymatic (SOD) or
non-enzymatic (cytochrome c, α-tocopherol and Trolox) O2
U−
scavengers were added to Tris-treated PSII membranes prior to the
illumination, IP to HPred conversion of cyt b559 was prevented (Fig.
4A). Fig. 4C shows that SOD and cytochrome c completely sup-
pressed the light-induced generation of O2
U−. It was observed that
α-tocopherol and Trolox interacted with EMPO–OOH adduct in the
dark, however, SOD and cytochrome c did not show any such
effects.
In order to test the effect of O2
U− scavengers on light-induced
conversion of cyt b559 from HPred to IP form, HPred cyt b559 was ﬁrstly
generated by pre-illumination of Tris-treated PSII membranes for
100 s followed by addition of O2
U− scavengers and re-illumination for
200 s. It was observed that in the presence of O2
U− scavengers, the
reverse conversion from HPred to IP form of cyt b559 was prevented
(Fig. 4B). Fig. 4D demonstrates the effect of O2
U− scavengers on
formation of EMPO–OOH adduct signal upon re-illumination. The
EMPO spin trap and O2
U− scavengers were added in 100 s pre-
illuminated PSII membranes prior to re-illumination (Fig. 4D).
Addition of catalase to Tris-treated PSII membranes prior to the
illumination has no effect on IP to HPred conversion of cyt b559 (Fig. 5A,Fig. 4. Effect of superoxide scavengers on the light-induced redox changes of cyt b559 and s
treated PSII membranes. (C, D) Light-induced EPR spin-trapping spectra of the EMPO–OOH a
scavengers. In B and D, the sample was ﬁrstly illuminated for 100 s in the absence of scaven
200 s. The concentrations of the scavengers were: 500 Uml−1 SOD, 400 μM cytochrome c, 50
were the same as in Figs. 1A and 3A, respectively.left column). Similarly, when HPred cyt b559 was ﬁrstly generated by
100 s pre-illumination of Tris-treated PSII membranes and further
catalase was added to prevent H2O2 formation, no effect of catalase on
conversion of HPred to IP cyt b559 was observed during re-illumination
(Fig. 5A, right column). These results reveal that the participation of
H2O2 in these reactions is unlikely, whereas it has been conﬁrmed that
the reversible photoconversion of IP↔HPred forms is a result of O2
U−
scavenger function of cyt b559.
3.4. Effect of exogenous source of superoxide on redox changes of cyt b559
To test the involvement of O2
U− in photoconversion of IP↔HPred
cyt b559, the effect of exogenous source of O2
U− on redox changes of cyt
b559 was studied. When KO2 in dry DMSO was added to Tris-treated
PSII membranes, formation of HPred cyt b559 was observed, whereas IP
cyt b559 was suppressed (Fig. 5B, left column). This reaction was
limited by amount of added KO2 and very short life of KO2 in aqueous
medium. Thus no further transformation of HPred form into IP form
was observed. In order to test the effect of exogenously generated O2
U−
on HPred cyt b559, HPred form was ﬁrst generated by illumination for
100 s and then KO2 in dry DMSO was mixed in these samples in the
dark. As a result of interaction of O2
U− with HPred form, HPred cyt b559
was diminished, whereas IP cyt b559 was generated which was
detected by further addition of sodium ascorbate (Fig. 5B, left
column). These results reveal that exogenously generated O2
U− also
caused the reversible conversion of IP↔HPred cyt b559.uperoxide production. (A, B) Light-induced redox difference spectra of cyt b559 in Tris-
dduct. In A and C, the sample (100 μg Chl ml−1) was illuminated in the presence of the
gers to generate HPred cyt b559 and after addition of scavengers further illuminated for
μMα-tocopherol and 250 μM Trolox. In (A, B) and (C, D) other experimental conditions
Fig. 5. Redox changes of cyt b559 by addition of the catalase and the exogenous source of
superoxide in dark and illuminated Tris-treated PSII membranes. (A) In the left column,
Tris-treated PSII membranes (100 μg Chl ml−1) were illuminated for 100 s in the
presence of 4000 U ml−1 catalase. In the right column, the sample (100 μg Chl ml−1)
was ﬁrstly illuminated for 100 s in the absence of catalase followed by the addition of
catalase and further illuminated for 200 s. (B) In the left column,1mMKO2 in dry DMSO
was added toTris-treated PSII membranes (100 μg Chl ml−1) in darkwhichwere having
cyt b559 in IP form. In the right column, 1 mM KO2 in dry DMSO was added in 100 s pre-
illuminated Tris-treated PSII membranes (100 μg Chl ml−1), which were having cyt b559
in HP form. Other experimental conditions were the same as in Fig. 1A.
Fig. 6. Effect of pH on the light-induced formation of HPred cyt b559. Tris-treated PSII
membranes (100 μg Chl ml−1) were illuminated for 100 s in 40mMMes– NaOH (pH 6.5)
or 40mMHepes (pH7–8). The pKa valuewasdetermined as pHvalue corresponding to the
half of HPred cyt b559. Other experimental conditions were the same as in Fig. 1B.
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It has been demonstrated that a change in the redox properties of
cyt b559 is accompanied by formation of the hydrogen bond between
the histidine ligand and the polypeptide backbone [14]. More recently,
the protonation of amino acid and formation of the hydrogen bond
between His22 and carbonyl group of α polypeptide was demon-
strated as an essential requirement for attaining HP form [15,16,49]. In
the light of these facts, we have examined the effect of pH on the light-
induced conversion of IP to HPred cyt b559 in Tris-treated PSII
membranes. As pH was increased above 6.5, the light-induced
formation of HPred cyt b559 was gradually decreased and completely
suppressed above pH 8 (Fig. 6). It can be seen that pH dependence of
HPred cyt b559 formation is sigmoidal with a pKa∼7.4. The observed
pKa value is within the range described for a histidine residue and thus
the ionizing group can be assigned to histidine [50]. Based on these
considerations it is proposed that the protonation of histidine seems
to be involved in the conversion of IP to HPred cyt b559. Therefore,subsequent steps in our investigations were focused on the modiﬁca-
tion of carboxyl and imidazole group separately in these polypeptides,
whichmight be playing an essential role in the re-establishing of HPred
form.
3.6. Effect of EDC and DEPC reversible photoconversion of IP↔HPred cyt b559
The main reactive groups responsible for the conversion of IP to
HPred cyt b559 have been identiﬁed by using the selective modiﬁcation
of the carboxyl groups and the imidazole groups in Tris-treated PSII
membranes. Participation of carboxyl group in the conversion of IP to
HPred cyt b559 was investigated using a water-soluble carbodiimide 1-
ethyl-3-[(3-dimethylamino)propyl] carbodiimide (EDC), a chemical
modiﬁer of free carboxyl group of the amino acid residues. It is known
that EDC couples the carboxyl groups to the primary amines, whereas
an amine-reactive O-acylisourea is forming as an intermediate [51]. To
study the involvement of histidine in the light-induced conversion of
IP to HPred cyt b559, diethyl pyrocarbonate (DEPC) was used, which is
known to substitute proton at nitrogen on the imidazole ring, whereas
the other nitrogen is not affected [45]. Fig. 7A and B show that
replacement of protonwith either of the modiﬁcation agents does not
affect the dark state of cyt b559. The observation that the light-induced
formation of HPred cyt b559 was observed in Tris-treated PSII
membranes containing the modiﬁed carboxyl groups reveals that
the involvement of carboxyl group in IP to HPred conversion is unlikely.
However, the conversion of IP to HPred cyt b559 upon illumination was
completely prevented in Tris-treated PSII membranes that contain
modiﬁed imidazole ring of histidine residues (Fig. 7B). Based on the
fact that the modiﬁcation of imidazole group was performed in Tris-
treated PSII membranes, where cyt b559 is in the deprotonated IP state,
the complete adduct of imidazole-DEPC complex could be formed.
Thus, it is evident that the preclusion of protonation of the imidazole
group was solely responsible reason for the loss of conversion from IP
to HPred form of cyt b559.
4. Discussion
In this study, light-induced redox, redox potential and acid-base
properties of cyt b559 were studied in PSII membranes depleted of the
water-splitting manganese complex by Tris treatment. The results
obtained showed that illumination of Tris-treated PSII membranes
results in the reversible photoconversion of cyt b559 from IP↔HPred
form comprising of 1) the conversion of IP (Em∼+125 mV) to HPred
(Em∼+310 mV) form and 2) the reverse conversion of HPred to IP
form (Figs. 1, 2). In accordance with these observations, it has been
previously demonstrated that the application of continuous or pulsed
Fig. 7. Redox changes of cyt b559 in dark and upon illumination in Tris-treated PSII
membranes with modiﬁed amino acid. (A) Redox difference spectra of cyt b559
measured in dark and after illumination in Tris-treated PSII membranes with modiﬁed
carboxyl group. Modiﬁcation of the carboxyl groups was performed using EDC
treatment. After modiﬁcation, the sample (100 μg Chl ml−1) was illuminated for
100 s in 50 mMMes– NaOH (pH 6.5). (B) Redox difference spectra of cyt b559 measured
in dark and after illumination in Tris-treated PSII membranes with modiﬁed imidazole
ring. Modiﬁcations of the imidazole ring were performed using DEPC treatment. The
sample (100 μg Chl ml−1) was illuminated for 100 s in 50 mM Mes (pH 5.5).
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b559 [12]. The dual model proposed by Barber and De Las Rivas [26,49],
which described pH-dependent interconversion between LP and HP
forms with protonation/deprotonation reactions is found to be in
good agreement with the current work. We demonstrated O2
U− as a
key regulator responsible for the reversible conversion between IP and
HPred form of cyt b559.
4.1. Role of superoxide in the photoconversion of IP↔HPred cyt b559
Using EPR spin-trapping technique, we have demonstrated that
O2
U− is produced in Tris-treated PSII membranes upon illumination
(Fig. 3). Due to the lack of electron donation form water-splitting
manganese complex to PSII in Tris-treated PSII membranes, the
source of electron to molecular oxygen is likely different from that
proposed in fully active PSII membranes [29,34,52]. Based on the
observation that O2
U− scavengers prevented IP to HPred conversion ofcyt b559, the involvement of O2
U− is substantiated in the conversion
of cyt b559 from IP to HPred form (Fig. 4). This proposal has been
supported by the observation that exogenously generated O2
U−
caused conversion of IP↔HPred cyt b559 (Fig. 5B). An interaction of
O2
U− with ferric heme iron is proposed to result in the formation of
ferrous heme iron, whereas O2 is released as by-product
IP cyt b559ðFe3þÞ þ OU−2 þ Hþ→HP cyt b559ðFe2þÞðHþÞ þ O2: ðAÞ
As the midpoint redox potential of the O2/O2
U− redox couple (pH
7) and Fe3+/Fe2+ redox couple in IP form of cyt b559 is−160 mV [53]
and 125 mV (Fig. 2A), respectively, the reduction of ferric heme iron
by O2
U− is favorable from thermodynamic point of view. Similarly, the
observation that the reverse conversion of HPred to IP form of cyt b559
is suppressed by O2
U− scavengers indicates that O2
U− is involved in the
reverse conversion of HPred to IP form of cyt b559 (Fig. 4). The fact that
exogenously generated O2
U− caused reverse conversion of HPred↔ IP
cyt b559 (Fig. 5B) conﬁrmed the involvement of O2
U− in conversion of
HPred↔ IP cyt b559. It is proposed that the interaction of protonated
form of superoxide HO2U (hydroperoxyl radical) with ferrous heme
iron results in the formation of ferric heme iron and H2O2.
HP cyt b559ðFe2þÞðHþÞ þ HOU2→IP cyt b559ðFe3þÞ þ H2O2: ðBÞ
The midpoint redox potential of Fe3+/Fe2+ redox couple in HP
form of cyt b559 and midpoint redox potential of the O2
U−/H2O2 redox
couple are 310 mV (Fig. 2B) and 890 mV (pH 7) [53], respectively.
Thus, the ferrous heme iron might reduce O2
U− to H2O2. It is proposed
that interacting species is presumably HO2
U because it carries an
additional proton to the heme as well as in this form it can be more
easily diffusible inside the membrane.
4.2. Role of protonation of histidine residue in the photoconversion of
IP↔HPred cyt b559
The observation that photoconversion of IP to HPred cyt b559 is
completely suppressed above pH 8 indicates that protonation of
amino acid is essential for the formation of HPred cyt b559 (Fig. 6). The
pKa∼7.4 determined from pH dependence of the photoconversion of
IP to HPred cyt b559 is closed to pKa value of protonation of the
imidazole group. It has been shown that pKa of the imidazole ring
ranges between pH 6 and 8 with a particular value modulated by its
environment within the proteins [50]. In accordance with this, it has
been previously suggested that in LPox form of cyt b559, one of the
hydrogen bond between imidazole ring of histidine and carbonyl
group of polypeptides is absent [14,15]. Based on these suggestions, it
has been proposed that the protonation/deprotonation reactions
regulate the conversion between the two states of cyt b559 [15,16,49].
Selective modiﬁcation of the imidazole groups using histidine-
modifying reagent DEPC showed that imidazole groups of histidine is
involved in photoconversion of IP to HPred cyt b559. Thus, it could be
concluded that protonation of the axial histidine is an essential
requirement for formation of HP form. In accordance with our
observation, it has been previously demonstrated that protonation
of histidine residue coordinated to the heme might play a crucial role
in the determination of redox potential properties of cyt b559 [15].
4.3. Superoxide dismutase activity of cyt b559
On the basis of the results presented in this study, a model for SOO
and SOR activity of cyt b559 is proposed. The model shows a plausible
explanation of superoxide-induced conversion of cyt b559 from IP to
HPred form as well as the reverse conversion of HPred to IP form
(Scheme 1). Reaction pathways in the redox active metal of super-
oxide-scavenger enzymes are assigned by electronic properties of the
metal, which is tuned by coordinated ligands and hydrogen bond with
nearby amino acid [38,54–56]. It is well known that the redox active
Scheme 1. Proposed model for the mechanisms of the involvement of ferric and ferrous heme iron intermediates in the SOO and the SOR activity of cyt b559.
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reduce O2
U− depending on the oxidation state of the metal and the
protonation state of the nearby residues [38,57,58]. Here, it is proposed
that the uprotonated IP form of cyt b559 serves as SOO that catalyze the
one-electron oxidation of O2
U− to O2 (equation A). On the other hand,
the protonatedHPred formof cyt b559 acts as SOR known to catalyze the
one-electron reduction of O2
U− to H2O2 (equation B). We suggest that
these are redox state, redox potential and acid/base properties of cyt
b559, which modulate SOO and SOR activity of cyt b559. Moreover, α-
helix of cyt b559 is exposed to the exterior through a large cavity, which
is present at the stromal surface of thylakoid membrane [8,59]. As the
heme is exposed to this cavity, the interior of the cavity can have an
inﬂuence on the redox state of cyt b559 [59]. Although the walls of this
cavity are covered by hydrophobic groups, any change in the
hydrophobic environment around the heme may cause it to become
more accessible to solvent and favor low redox potential forms. These
structural details strongly support the feasibility on the mechanism
aspects of superoxide oxidation and reduction by HPred and IP forms,
respectively, as described in our study.
4.3.1. Superoxide oxidase activity of cyt b559
Based on the fact that ferric heme iron has been proposed to be
located near to the membrane edge in the less hydrophobic
environment [13], the accessibility of O2
U− to ferric heme iron is
feasible. The negative charge carried by O2
U− attracts it towards
ferric heme iron, and results in reduction of the ferric heme iron by
O2
U−. Due to the strong attraction forces between the ferric heme
iron and electron cloud of nitrogen atom of the imidazole, it is
proposed that the reduction of ferric heme iron by O2
U− occurs as an
outer-sphere reaction, which does not involve the direct binding of
O2
U− to the ferric heme iron. In accordance with this assumption, it
has been recently demonstrated that oxidation of O2
U− by transition
metals process via an outer-sphere reaction pathway [60]. The fact
that the ferric heme iron is located near to the membrane edge
reveals that protons from the water phase are likely available for
protonation of the imidazole group. Furthermore, the reduction ofthe ferric heme iron increased the electrostatic strength of N1–H
bond and thus enhanced the afﬁnity for the protons. Protonation of
the N1 atom of imidazole ring makes environment around the heme
more hydrophobic and results in the formation of hydrogen bond
between imidazole N1–H group and the peptide backbone in the α-
helix. In accordance with this proposal, it has been shown that the
formation of hydrogen bond caused a structural change that
increases the hydrophobicity around the heme and stabilizes the
ferrous heme iron [15].
4.3.2. Superoxide reductase activity of cyt b559
Based on the fact that ferrous heme iron is incorporatedmore deep
in the membrane in a more hydrophobic environment [13], it is likely
that the ferrous heme iron interacts with HO2
U that could penetrate
more easily inside the hydrophobic domain of the membrane. Due to
the fact that HO2
U is a neutral radical, the lack of the charge facilitates
HO2
U to penetrate to the ferrous heme iron and maintain its oxidation
to the ferric heme iron. It is proposed that the ferrous heme iron
generates less attraction force and weaker interaction with histidine
ligand due to its less positive charge thereby causing shift of the
electron cloud of nitrogen away from the ferrous heme iron. In such a
case, it seems favorable that the interaction of hydroperoxyl radical
with ferrous heme iron process via an inner-sphere reaction pathway.
In accordance with this proposal, the reduction of superoxide by
ferrous iron was suggested to proceed via the inner-sphere mechan-
ism [61]. Based on the analogy with SOR, the inner-sphere electron
transfer from the ferrous heme iron to hydroperoxyl radical is
proposed to result in formation of the ferric-hydroperoxo intermedi-
ate (Scheme I) [62–64]. Because ferrous heme iron is incorporated
deeper into the hydrophobic domain of membrane, the delivery of
protons to redox active site is limited. It is proposed that oxidation of
ferrous to ferric heme iron decreased the electrostatic strength of N1–
H bond and thus lowered the afﬁnity for the protons. It seems
reasonable that deprotonation of the N1–H of histidine may also
provide a second proton to proximal oxygen of ferric-hydroperoxo
intermediate during the formation of H2O2. Previously, formation of
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hydroperoxo species, formed in another b-type of cytochrome, cyt
P450 [65]. The protonation of proximal oxygen immediately results
in the cleavage of heme-oxygen bridge. Thus, dissociation of H2O2 as a
product is followed by restoration of the sixth coordination of ferric
iron with nitrogen of imidazole ring. Recently, it has been suggested
for SOR enzymatic cycle that the proximal oxygen coordinated to
ferric iron is replaced by axial glutamate (Glu47) residue with
liberation of H2O2 [66].
4.4. Physiological relevance
Three dimensional structure of PSII from thermophilic cyanobacteria
showed that cofactors on the electron acceptor side of PSII are far away
from the heme iron to sufﬁciently maintain a direct electron transfer
reaction (heme iron is located approximately 50 Å and 30 Å from
pheophytins of D1 andD2proteins, respectively; it is 50Å and 30Å away
from primary quinone acceptor (QA) and secondary quinone acceptor
(QB) binding sites, respectively) [7,8]. Based on the results presented in
this study, it seems likely that O2
U− as a dangerous secondary by-product
coming from inadequate PSII might sufﬁciently fulﬁll the function of an
electron transport carrier between these cofactors and heme iron. Light-
induced formation of O2
U− on PSII electron acceptor side provides an
alternativeway for electron transport between these cofactors andheme
iron of cyt b559 and thus might prevent over reduction of PSII electron
acceptor side. The light-induced transformation between redox poten-
tial forms of cyt b559 has not been reported in control PSII membranes
yet; however, the presentmodel has demonstrated the SOO and the SOR
function of cyt b559 based on the light-induced transformation between
redox potential forms of cyt b559 in donor side inhibited PSII complex
which are more often present in natural environment during photo-
inhibitory conditions.
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